EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

A randomized trial to evaluate the effect of epigallocatechin gallate (EGCG) on EBV reactivation in patients with nasopharyngeal carcinoma in remission -the TCOG T2312 study

Hui-Jen Tsai, Skye Hung-Chun Cheng, Shih-Neng Yang, Hsiao-Hui Tsou, Chin-Fu Hsiao, Yi-Fang Chang, Wen-Shan Liu, Jo-Ting Tsai, Ching-Yun Hsieh, Yu-Chen Tsai, Ming-Hsui Tsai, Jeng-Yuh Ko und 8 weitere

European Journal of Cancer · 2026-11 · 248 · 117445

DOI: 10.1016/j.ejca.2026.117445 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Hui-Jen Tsai und 19 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; Department of Oncology, National Cheng Kung University Ho…. Hauptthemen laut MEDLINE: Catechin, Epstein-Barr Virus Infections, Herpesvirus 4, Human, Nasopharyngeal Carcinoma. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CatechinEpstein-Barr Virus InfectionsHerpesvirus 4, HumanNasopharyngeal CarcinomaNasopharyngeal NeoplasmsVirus ActivationAdultAgedFemaleHumansMaleMiddle AgedYoung AdultCarcinomaDNA, ViralNeoplasm Recurrence, LocalRemission InductionSecondary Prevention

Stichwörter der Autor:innen

EBV reactivationEpigallocatechin gallate (EGCG)Nasopharyngeal carcinomaRandomized clinical trial

Substanzen

CatechinDNA, Viralepigallocatechin gallate

Autor:innen und Institutionen

  • National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, T…
  • Department of Radiation Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei City, Taiwan; Department of Radiation Oncology, Taitung Christian Hospital, Taitung City, Taitung County, Taiwan.
  • Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung City, Taiwan.
  • Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
  • Department of Hematology and Oncology, MacKay Memorial Hospital, Taipei, Taiwan.
  • Department of Radiation Oncology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.

Förderung

  • National Science and Technology Council

Zitieren

APA

Tsai, H. J., Cheng, S. H., Yang, S. N., Tsou, H. H., Hsiao, C. F., Chang, Y. F., Liu, W. S., Tsai, J. T., Hsieh, C. Y., Tsai, Y. C., Tsai, M. H., Ko, J. Y., Hua, C. H., Ting, L. L., Lien, M. Y., Wu, Y. H., Tsai, S. T., Chen, J. Y., Lin, J. C., & Liu, T. W. (2026). A randomized trial to evaluate the effect of epigallocatechin gallate (EGCG) on EBV reactivation in patients with nasopharyngeal carcinoma in remission -the TCOG T2312 study. European Journal of Cancer, 248, 117445. https://doi.org/10.1016/j.ejca.2026.117445

Vancouver

Tsai HJ, Cheng SH, Yang SN, Tsou HH, Hsiao CF, Chang YF, et al. A randomized trial to evaluate the effect of epigallocatechin gallate (EGCG) on EBV reactivation in patients with nasopharyngeal carcinoma in remission -the TCOG T2312 study. European Journal of Cancer. 2026;248:117445. doi:10.1016/j.ejca.2026.117445

BibTeX
@article{Tsai2026,
  author = {Tsai, Hui-Jen and Cheng, Skye Hung-Chun and Yang, Shih-Neng and Tsou, Hsiao-Hui and Hsiao, Chin-Fu and Chang, Yi-Fang and Liu, Wen-Shan and Tsai, Jo-Ting and Hsieh, Ching-Yun and Tsai, Yu-Chen and Tsai, Ming-Hsui and Ko, Jeng-Yuh and Hua, Chun-Hung and Ting, Lai-Lei and Lien, Ming-Yu and Wu, Yuan-Hua and Tsai, Sen-Tien and Chen, Jen-Yang and Lin, Jin-Ching and Liu, Tsang-Wu},
  title = {A randomized trial to evaluate the effect of epigallocatechin gallate (EGCG) on EBV reactivation in patients with nasopharyngeal carcinoma in remission -the TCOG T2312 study},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117445},
  doi = {10.1016/j.ejca.2026.117445}
}
Kostenlos starten →